US HB1344 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 22-0)
Status: Introduced on February 25 2019 - 25% progression, died in committee
Action: 2019-03-25 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Pending: House Subcommittee on Antitrust, Commercial, and Administrative Law Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Competitive DRUGS Act of 2019 Competitive Deals Resulting in Unleashed Generics and Savings Act of 2019

Sponsors


History

DateChamberAction
2019-03-25HouseReferred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
2019-02-26HouseReferred to the Subcommittee on Health.
2019-02-25HouseReferred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-25HouseReferred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-25HouseReferred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-25HouseReferred to the Subcommittee on Health.
2019-02-25HouseIntroduced in House

Same As/Similar To

HB2375 (Related) 2020-12-24 - Placed on the Union Calendar, Calendar No. 576.
SB64 (Related) 2019-01-09 - Read twice and referred to the Committee on the Judiciary.

Subjects


US Congress State Sources


Bill Comments

LegiScan Search

View Top 50 Searches

Select area of search.
Find an exact bill number.
Search bill text and data. [help]
Reset

LegiScan Trends

View Top 50 National

MS SR80 Commend extensive judicial career and service of Mississippi Court of Appeals...
GA HB1078 Community Health, Department of; Georgia Program of All-Inclusive Care...
CO HB1014 Deceptive Trade Practice Significant Impact Standard
IL HR0708 CONGRATS-LCHS GIRLS BBALL TEAM
LA HB577 Prohibits social media companies from collecting data to use for targeted...
FL S0440 Utility Terrain Vehicles
IL SB0378 CHILDREN-TECH
IL HB0340 EDUCATION-TECH
NY A05729 Requires insurers to provide coverage for tattooing of the nipple-areolar...
VA SB425 Health insurance; ethics and fairness in carrier business practices.
feedback